Found: 31
Select item for more details and to access through your institution.
MicroRNA-29b reduces myocardial ischemia–reperfusion injury in rats via down-regulating PTEN and activating the Akt/eNOS signaling pathway.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 123, doi. 10.1007/s11239-021-02535-y
- By:
- Publication type:
- Article
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 20, doi. 10.1007/s11239-021-02534-z
- By:
- Publication type:
- Article
Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study).
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 103, doi. 10.1007/s11239-021-02527-y
- By:
- Publication type:
- Article
The first report of a JAK2 V617F-positive myeloproliferative neoplasm with initial manifestation as a rare pampiniform venous plexus thrombosis and review of the literature.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 213, doi. 10.1007/s11239-021-02525-0
- By:
- Publication type:
- Article
Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 182, doi. 10.1007/s11239-021-02520-5
- By:
- Publication type:
- Article
Overexpression of miR-1298 attenuates myocardial ischemia–reperfusion injury by targeting PP2A.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 136, doi. 10.1007/s11239-021-02540-1
- By:
- Publication type:
- Article
Risk of recurrent venous thromboembolism and bleeding in patients with interstitial lung disease: a cohort study.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 67, doi. 10.1007/s11239-021-02518-z
- By:
- Publication type:
- Article
Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 74, doi. 10.1007/s11239-021-02530-3
- By:
- Publication type:
- Article
Apixaban and rivaroxaban anti-Xa level utilization for guidance of administration of andexanet alfa: a case series.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Neutrophil activation and circulating neutrophil extracellular traps are increased in venous thromboembolism patients for at least one year after the clinical event.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 30, doi. 10.1007/s11239-021-02526-z
- By:
- Publication type:
- Article
Rotational thromboelastometry and conventional coagulation tests in patients undergoing major cardiac or aortic surgery: a retrospective single-center cohort study.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 149, doi. 10.1007/s11239-021-02519-y
- By:
- Publication type:
- Article
Adverse consequences of immediate thrombolysis-related complications: a multi-centre registry-based cohort study of acute stroke.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 218, doi. 10.1007/s11239-021-02523-2
- By:
- Publication type:
- Article
Patients with autoimmune chronic inflammatory diseases present increased biomarkers of thromboinflammation and endothelial dysfunction in the absence of flares and cardiovascular comorbidities.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 10, doi. 10.1007/s11239-021-02517-0
- By:
- Publication type:
- Article
Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 58, doi. 10.1007/s11239-021-02514-3
- By:
- Publication type:
- Article
Association of lipoprotein(a) with intrinsic and on-clopidogrel platelet reactivity.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 1, doi. 10.1007/s11239-021-02515-2
- By:
- Publication type:
- Article
U shape association of hemoglobin level with in-hospital mortality for COVID-19 patients.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 113, doi. 10.1007/s11239-021-02516-1
- By:
- Publication type:
- Article
Inhibitory effects of amniotic fluid on the activated protein C anticoagulation system in maternal plasma.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 208, doi. 10.1007/s11239-021-02513-4
- By:
- Publication type:
- Article
Incidence and patient characteristics of venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 202, doi. 10.1007/s11239-021-02511-6
- By:
- Publication type:
- Article
Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 96, doi. 10.1007/s11239-021-02507-2
- By:
- Publication type:
- Article
Practice patterns surrounding referral to a specialty venous thromboembolism (VTE) clinic: a retrospective review.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 176, doi. 10.1007/s11239-021-02503-6
- By:
- Publication type:
- Article
The clot thickens—enhanced integration of stroke and thrombosis training.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 17, doi. 10.1007/s11239-021-02502-7
- By:
- Publication type:
- Article
Use of direct oral anticoagulants in chronic thromboembolic pulmonary hypertension: a systematic review.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 51, doi. 10.1007/s11239-021-02501-8
- By:
- Publication type:
- Article
Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 118, doi. 10.1007/s11239-021-02499-z
- By:
- Publication type:
- Article
Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 167, doi. 10.1007/s11239-021-02495-3
- By:
- Publication type:
- Article
Causal effect of renal function on venous thromboembolism: a two-sample Mendelian randomization investigation.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 43, doi. 10.1007/s11239-021-02494-4
- By:
- Publication type:
- Article
Impact of a pharmacist driven anticoagulation reversal program at a large academic medical center.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 158, doi. 10.1007/s11239-021-02491-7
- By:
- Publication type:
- Article
Relations between left atrial appendage contrast retention and thromboembolic risk in patients with atrial fibrillation.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 191, doi. 10.1007/s11239-021-02490-8
- By:
- Publication type:
- Article
Association between previous anticoagulant use and mortality among hospitalized patients with COVID-19.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 88, doi. 10.1007/s11239-021-02489-1
- By:
- Publication type:
- Article
Transient endothelial injury and release of lupus anticoagulant in COVID-19.
- Published in:
- 2022
- By:
- Publication type:
- Letter
ICODE: the international COVID-19 thrombosis biomarkers colloquium—novel soluble biomarkers: circulating cell-free nucleic acids and other molecules.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 53, n. 1, p. 83, doi. 10.1007/s11239-021-02468-6
- By:
- Publication type:
- Article
Increased incidence of massive hemorrhage at uncommon sites after initiation of systemic anticoagulation in critically ill patients with coronavirus disease 2019 (COVID-19) infection.
- Published in:
- 2022
- By:
- Publication type:
- Letter